KBC Ancora SA (EBR:KBCA)

Kronos Bio Income Statement

Financials in millions EUR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Selling, General & Admin	3.16	3.05	2.74	2.86	2.38	2.24
Other Operating Expenses	-0.01	0.14	0.29	0.36	-0.05	-0.04
Operating Expenses	3.16	3.19	3.02	3.23	2.33	2.2
Operating Income	-3.16	-3.19	-3.02	-3.23	-2.33	-2.2
Interest Expense	-5.55	-6.79	-8.96	-13.61	-13.82	-14.47
Interest & Investment Income	378.05	378.27	310.93	821.67	34.11	77.52
Other Non Operating Income (Expenses)	-0	-0	-0.08	-0.01	-0	-0
EBT Excluding Unusual Items	369.34	368.29	298.87	804.83	17.96	60.85
Gain (Loss) on Sale of Investments	-	-	-	-	511.73	-
Pretax Income	369.34	368.29	298.87	804.83	529.68	60.85
Net Income	369.34	368.29	298.87	804.83	529.68	60.85
Net Income to Common	369.34	368.29	298.87	804.83	529.68	60.85
Net Income Growth	22.93%	23.23%	-62.87%	51.94%	770.50%	-76.02%
Shares Outstanding (Basic)	77	77	77	78	78	78
Shares Outstanding (Diluted)	77	77	77	78	78	78
Shares Change (YoY)	-	-	-1.63%	-0.01%	0.37%	-0.39%
EPS (Basic)	4.80	4.78	3.88	10.28	6.76	0.78
EPS (Diluted)	4.80	4.78	3.88	10.28	6.76	0.78
EPS Growth	22.93%	23.23%	-62.25%	51.97%	767.26%	-75.93%
Dividend Per Share	-	4.090	3.310	8.790	0.200	-
Dividend Growth	-	23.57%	-62.34%	4295.00%	-	-
EBIT	-3.16	-3.19	-3.02	-3.23	-2.33	-2.2
Revenue as Reported	0.01	0.01	0.02	0.04	0.05	0.04

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.